Literature DB >> 23283489

Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation.

Budd A Tucker1, Kristin R Anfinson, Robert F Mullins, Edwin M Stone, Michael J Young.   

Abstract

The purpose of this study was to determine whether a proprietary xeno-free synthetic culture surface could be used to aid in the production and subsequent retinal-specific differentiation of clinical-grade induced pluripotent stem cells (iPSCs). iPSCs were generated using adult somatic cells via infection with either a single cre-excisable lentiviral vector or four separate nonintegrating Sendai viruses driving expression of the transcription factors OCT4, SOX2, KLF4, and c-MYC. Retinal precursor cells were derived via targeted differentiation of iPSCs with exogenous delivery of dkk-1, noggin, insulin-like growth factor-1, basic fibroblast growth factor, acidic fibroblast growth factor, and DAPT. Phase contrast microscopy, immunocytochemistry, hematoxylin and eosin staining, and reverse transcription-polymerase chain reaction were used to determine reprogramming efficiency, pluripotency, and fate of undifferentiated and differentiated iPSCs. Following viral transduction, cells underwent prototypical morphological changes resulting in the formation of iPSC colonies large enough for manual isolation/passage at 3-4 weeks postinfection. Both normal and disease-specific iPSCs expressed markers of pluripotency and, following transplantation into immune-compromised mice, formed teratomas containing tissue comprising all three germ layers. When subjected to our established retinal differentiation protocol, a significant proportion of the xeno-free substrate-derived cells expressed retinal cell markers, the number of which did not significantly differ from that derived on traditional extracellular matrix-coated dishes. Synthetic cell culture substrates provide a useful surface for the xeno-free production, culture, and differentiation of adult somatic cell-derived iPSCs. These findings demonstrate the potential utility of these surfaces for the production of clinical-grade retinal neurons for transplantation and induction of retinal regeneration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23283489      PMCID: PMC3659741          DOI: 10.5966/sctm.2012-0040

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  25 in total

1.  Isolation and cultivation of human iris pigment epithelium.

Authors:  D N Hu; R Ritch; S A McCormick; K Pelton-Henrion
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-07       Impact factor: 4.799

2.  Human embryonic stem cells express an immunogenic nonhuman sialic acid.

Authors:  Maria J Martin; Alysson Muotri; Fred Gage; Ajit Varki
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

3.  Isolation, characterization, and culture of epithelial stem cells.

Authors:  Jackie R Bickenbach
Journal:  Methods Mol Biol       Date:  2005

4.  Notch 1 inhibits photoreceptor production in the developing mammalian retina.

Authors:  Ashutosh P Jadhav; Heather A Mason; Constance L Cepko
Journal:  Development       Date:  2006-02-01       Impact factor: 6.868

5.  Human induced pluripotent stem cells derived under feeder-free conditions display unique cell cycle and DNA replication gene profiles.

Authors:  Henry C Y Chung; Ruby C Y Lin; Grant J Logan; Ian E Alexander; Perminder S Sachdev; Kuldip S Sidhu
Journal:  Stem Cells Dev       Date:  2011-06-01       Impact factor: 3.272

6.  Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse.

Authors:  M Mukhopadhyay; S Shtrom; C Rodriguez-Esteban; L Chen; T Tsukui; L Gomer; D W Dorward; A Glinka; A Grinberg; S P Huang; C Niehrs; J C Izpisúa Belmonte; H Westphal
Journal:  Dev Cell       Date:  2001-09       Impact factor: 12.270

7.  Skin keratinocytes pre-treated with embryonic stem cell-conditioned medium or BMP4 can be directed to an alternative cell lineage.

Authors:  K L Grinnell; J R Bickenbach
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

8.  Neural induction by the secreted polypeptide noggin.

Authors:  T M Lamb; A K Knecht; W C Smith; S E Stachel; A N Economides; N Stahl; G D Yancopolous; R M Harland
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

Review 9.  Xeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges.

Authors:  Ting Lei; Sandrine Jacob; Imen Ajil-Zaraa; Jean-Bernard Dubuisson; Olivier Irion; Marisa Jaconi; Anis Feki
Journal:  Cell Res       Date:  2007-08       Impact factor: 25.617

10.  Chordin and noggin promote organizing centers of forebrain development in the mouse.

Authors:  Ryan M Anderson; Alison R Lawrence; Rolf W Stottmann; Daniel Bachiller; John Klingensmith
Journal:  Development       Date:  2002-11       Impact factor: 6.868

View more
  62 in total

Review 1.  Gene therapy using stem cells.

Authors:  Erin R Burnight; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-13       Impact factor: 6.915

Review 2.  Stem cell therapies for retinal diseases: recapitulating development to replace degenerated cells.

Authors:  Cuiping Zhao; Qingjie Wang; Sally Temple
Journal:  Development       Date:  2017-04-15       Impact factor: 6.868

3.  Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.

Authors:  Erin R Burnight; Manav Gupta; Luke A Wiley; Kristin R Anfinson; Audrey Tran; Robinson Triboulet; Jeremy M Hoffmann; Darcey L Klaahsen; Jeaneen L Andorf; Chunhua Jiao; Elliott H Sohn; Malavika K Adur; Jason W Ross; Robert F Mullins; George Q Daley; Thorsten M Schlaeger; Edwin M Stone; Budd A Tucker
Journal:  Mol Ther       Date:  2017-06-12       Impact factor: 11.454

4.  Generation of highly enriched populations of optic vesicle-like retinal cells from human pluripotent stem cells.

Authors:  Sarah K Ohlemacher; Clara L Iglesias; Akshayalakshmi Sridhar; David M Gamm; Jason S Meyer
Journal:  Curr Protoc Stem Cell Biol       Date:  2015-02-02

5.  Transplantation of iPSC-derived TM cells rescues glaucoma phenotypes in vivo.

Authors:  Wei Zhu; Oliver W Gramlich; Lauren Laboissonniere; Ankur Jain; Val C Sheffield; Jeffrey M Trimarchi; Budd A Tucker; Markus H Kuehn
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

Review 6.  Substrates for clinical applicability of stem cells.

Authors:  Sanjar Enam; Sha Jin
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

7.  Advanced Materials to Enhance Central Nervous System Tissue Modeling and Cell Therapy.

Authors:  Riya J Muckom; Rocío G Sampayo; Hunter J Johnson; David V Schaffer
Journal:  Adv Funct Mater       Date:  2020-08-12       Impact factor: 18.808

8.  Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy.

Authors:  Luke A Wiley; Kristin R Anfinson; Cathryn M Cranston; Emily E Kaalberg; Malia M Collins; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Curr Protoc Stem Cell Biol       Date:  2017-08-14

Review 9.  Use of human pluripotent stem cells to study and treat retinopathies.

Authors:  Karim Ben M'Barek; Florian Regent; Christelle Monville
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

10.  CEP290 gene transfer rescues Leber congenital amaurosis cellular phenotype.

Authors:  E R Burnight; L A Wiley; A V Drack; T A Braun; K R Anfinson; E E Kaalberg; J A Halder; L M Affatigato; R F Mullins; E M Stone; B A Tucker
Journal:  Gene Ther       Date:  2014-05-08       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.